Larimar Therapeutics Inc (LRMR) Stock Analysis
Verdict: HOLD
Heavy insider buying and deep analyst support contrast with a rapid cash burn, making this a binary play on CTI-1601 clinical data.
Investment score: 64/100
Analysis as of
Is Larimar Therapeutics Inc stock worth reviewing? AI model thesis
LRMR is a high-conviction speculative buy based on aggressive insider accumulation and a leading position in the FA treatment landscape.
7-factor investment score
- Valuation: 55/100 (weight 20%)
- Financial Health: 40/100 (weight 15%)
- Technical Momentum: 50/100 (weight 15%)
- Earnings Quality: 60/100 (weight 15%)
- Insider Sentiment: 95/100 (weight 10%)
- Analyst Consensus: 90/100 (weight 10%)
- Risk-Adjusted Return: 55/100 (weight 15%)
Larimar Therapeutics Inc opportunities and risks
What speaks for LRMR
- Aggressive Insider Accumulation
What speaks against LRMR
- Imminent Cash Runway Exhaustion
Peers and competitors
| Ticker | P/E | P/S | EV/EBITDA | Gross margin | Net margin | FCF yield |
|---|---|---|---|---|---|---|
| LRMR | n/a | 0.0x | n/a | 0.0% | 0.0% | -41.5% |
| EBS | n/a | 0.6x | 5.2x | 44.4% | -1.3% | 34.4% |
| DMAC | n/a | 0.0x | n/a | 0.0% | 0.0% | -7.9% |
| USBC | n/a | 0.0x | n/a | 0.0% | 0.0% | -12.2% |
| STRO | n/a | 2.3x | n/a | 98.7% | -154.2% | -66.7% |
| UPB | n/a | 114.8x | n/a | 98.5% | -4719.0% | -36.7% |
| Peer median | n/a | 0.6x | n/a | 44.4% | -1.3% | -12.2% |
Frequently asked questions about Larimar Therapeutics Inc (LRMR)
Is LRMR stock a good investment?
The cached TradeMates AI model rates Larimar Therapeutics Inc as HOLD with an investment score of 64/100. LRMR is a high-conviction speculative buy based on aggressive insider accumulation and a leading position in the FA treatment landscape. This is algorithmic model output, not personal investment advice.
Is LRMR stock a buy?
The TradeMates model verdict for LRMR is HOLD with an investment score of 64/100. Treat this as a model signal to review, not a personal buy recommendation.